NCT00946686View on ClinicalTrials.gov

To Demonstrate the Relative Bioavailability, Parallel Study Of Leflunomide 20 mg Tablets Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

September 30, 2002

Primary Completion Date

September 30, 2002

Study Completion Date

September 30, 2002

Conditions
Rheumatoid ArthritisPsoriatic Arthritis
Interventions
DRUG

Leflunomide 20 mg Tablets (Geneva Pharmaceutical)

DRUG

Arava 20 mg Tablets (Aventis Pharmaceutical, Inc.)

Sponsors

Lead Sponsor

Sandoz
All Listed Sponsors
lead

Sandoz

INDUSTRY

NCT00946686 - To Demonstrate the Relative Bioavailability, Parallel Study Of Leflunomide 20 mg Tablets Under Fasting Conditions | Biotech Hunter | Biotech Hunter